ABSTRACT: A novel Amycolatopsis strain KCTC 29142 was isolated and characterized based on the polyphasic taxonomic analysis including morphological observation, phylogenetic analysis, physiological and chemotaxonomic characteristics. The ethyl acetate extract of strain KCTC 29142 culture broth showed strong antibacterial activity and the active compound was identified as siderochelin A, a ferrous-ion chelating compound. In this study, siderochelin A showed good activity against multi-drug resistant pathogens, including Acinetobacter baumanii, methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-resistant Staphylococcus aureus (VRSA), and Escherichia coli (E. coli ). The minimum inhibitory activity against clinical isolates was also determined.
Multi drug-resistant pathogens (MDRPs) are a critical worldwide problem because of their resistance to a bevy of commercially available antibiotics and their high mortality rate. Available evidence showed that the proportion of Gram-positive and negative bacteria resistant to commonly used antibiotics is increasing (Lode, 2009; Lin and Lan, 2014) . The mechanisms of this resistance are often complex, and include production of β-lactamases, upregulated efflux pumps, and target site mutations (Sakoulasand and Moellering, 2008) . It is reported that patients with infections due to MDRP have higher costs than do patients with infections due to antimicrobial-susceptible organisms (Cosgrove, 2006) . So it is necessary to develop new drugs for control of MDRP (Anderson, 2003) .
Iron is an essential bioelement for most bacteria, which involved in a variety of metabolic and informational cellular pathways (Miethke and Marahiel, 2007) . Since the importance 328 • Lee et al.
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of iron in the growth of bacteria, many studies has assessed the potential viability of iron chelators as therapeutic agents against various microbes (Chan et al., 2009; Kim and Shin, 2009 ).
Especially in the case of multi-drug resistant bacteria, which are no longer effective for treatment by antibiotics, iron chelators are assessed as alternative therapeutic agents (Thomson et al., 2012) .
Siderochelins, a ferrous-ion chelating agents, were first discovered from fermentation broth of Nocardia sp. SC11340 (Liu et al., 1981) . There are six analogues of siderochelin; siderochelin A and B (from Nocardia sp. SC11340), siderochelin C (from Actinomycetes sp.), and siderochelin D, E, F (from Amycolatopsis sp. LZ149) (Liu et al., 1981; Mitscher et al., 1984; Lu et al., 2015) . These siderochelins showed a broadspectrum of antibacterial activity, however, the inhibitory activity of siderochelins on MDRPs have not been studied yet.
Presently we report the phenotypic, physiological, chemotaxonomic, and phylogenetic characterization of a novel strain KCTC 29142 isolated from a soil sample collected from Ami Mountain, South Korea. The culture supernatant of this strain displayed inhibitory activities on MDRPs. The active compound was isolated and analyzed using 
Materials and Methods

Bacterial strain
Strain KCTC 29142 was isolated from the soil sample collected from Ami Mountain in Chungcheongnam-do province, Republic of Korea (latitude 36°50′50.4″N, 126°39′53.2″E) from February 23 2007. One gram of soil was suspended in 0.85% NaCl, and 100 μl of the suspension was spread on Humic acid-Vitamin (HV) agar medium, the plates were incubated at 28°C for 2 weeks. The single colony was picked using a sterile toothpick and streaked on Bennett's agar medium (glucose 10 g/L, peptone 2 g/L, yeast extract 1 g/L, beef extract 1 g/L, and agar 15 g/L) for cultivation. The strain was finally stored in 20% (v/v) glycerol suspensions at -80°C.
Morphological, physiological, and biochemical characteristics
Culture characteristics of strain KCTC 29142 were observed on International Streptomyces Project (ISP), Bennett's and S agar media (Shiring and Gottlieb, 1966; Baker, 1990) . The physiological and biochemical features of strain KCTC 29142
were determined according to previously described procedures (Waksman and Henrici, 1943; Becker et al., 1965) . Sugar utilization was evaluated by using ISP9 medium supplemented with 1% (w/v) of various sugars individually as sole carbon source. Nitrogen source utilization was assessed by degradation of casein, xanthine, gelatin, and tyrosine as described previously (Gordon et al., 1974) .
Phylogenetic analysis, DNA G+C content, and DNA-DNA hybridization Genomic DNA was extracted and purified using the ExgeneTM cell SV kit (GeneAll). The 16S rRNA gene was amplified using the universal primer set 27F/1492R (Lane, 1991) and sequenced by Solgent. The resulting 16S rRNA gene sequence (1.5 kb) was aligned with available 16S rRNA gene sequences using the EzTaxon-e server (http://eztaxon-e.ezbiocloud.net/) (Kim et al., 2012) . The 16S rRNA gene sequences of closely related type strains were obtained from the GenBank database and multiple alignments were conducted with the CLUSTAL_X program, version 1.8 (Thompson et al., 1997) . The phylogenetic tree was constructed with neighbor-joining (Saitou and Nei, 1987) and Tajima-Nei (Tajima and Nei, 1984 ) methods using MEGA 4 software (Tamura et al., 2007) . Robustness of individual branches was evaluated by bootstrapping of 1,000
replications. The G+C contents of the total DNA and DNA-DNA hybridization between the strain KCTC 29142 and the reference type strains were performed as described before (Lechevalier et al., 1986) .
Isolation and identification of antibacterial compound
The supernatant from flask fermentation was obtained following centrifugation and solvent partitioned in a step-wise 
Evaluation of the antibacterial activity
Antibacterial activity was measured by the disc diffusion method. Mueller-Hinton agar medium was mixed with 0.1 ml of bacterial suspension (10 5 CFU/ml). Paper discs which were soaked with 30 μg of EtOAc extract or siderochelin A were placed on the agar surface. The plates were incubated at 37°C
for 18 h, and the antibacterial activities were assessed by measuring the diameter of inhibition zone (mm).
Determination of the minimum inhibitory concentration (MIC)
MIC values of the siderochelin A against clinical isolates were determined by agar dilution method. Siderochelin A was added into the Mueller-Hinton (MH) agar at the concentration ranging from 0.06-128.00 μg/ml by two-fold serial dilution.
Ten microliters of each test strain was inoculated onto the agar surface by striking, and incubated at 28°C for 18 h. MIC was expressed as the lowest concentration of inhibited growth of visible colony on the agar surface.
Results and Discussion
Phylogenetic analysis, determination of DNA G+C content, and DNA-DNA hybridization
The phylogenetic tree affiliated strain KCTC 29142 with the genus Amylcolatopsis (Fig. 1 (Wayne et al., 1987) . The unique taxonomic position of strain KCTC 29142 determined by a polyphasic taxonomic approach has prompted the present suggestion of this strain as a new species of the genus Amycolatopsis.
The genus Amycolatopsis was first described by Lechevalier et al. (1986) . It is a member of the family Pseudonocardiaceae, in the phylum Actinobacteria and 65 species of the genus Amycolatopsis have been recognized (Euzéby, 1997) . Some species of this genus were reported to produce epoxyquinomicin C, vancomycin, rifomycin, rifamycin, and siderochelins (Sensi et al., 1959; Matsumoto et al., 1997; Wink et al., 2003; Bala et al., 2004; Lu et al., 2015) .
Morphological, physiological, and biochemical characteristics showed typical morphology of Amycolatopsis species, and the colors are sand yellow (Fig. 2) (optimum, 28°C) and pH 5-10 (optimum, pH 7). The optimal growth NaCl concentration was 0-2.5% (w/v, no growth on 5%), and was resistant to streptomycin (100 μg/ml), neomycin (50 μg/ml), and vancomycin (50 μg/ml). These characteristics were different with related type strains (Table 1) , which suggested it is an uncharacterized strain so far.
The phylum Actinobacteria, which includes the genus Streptomyces, has proven particularly important as a source of secondary metabolites include many antibiotics (Gao and Gupta, 2012) . Previously, many studies have been reported on the discovery of novel antibiotics from Actinobacteria which can inhibit the MDRPs, but mostly are from Streptomyces species ( Procópio et al., 2012; Cheng et al., 2013) . Recently, rare actinomycetes were recognized as a potential storehouse for novel antibiotics, and many studies were carried out to develop novel antibiotics from rare actinomycetes (Tiwari and Gupta, 2012 ).
Chemotaxonomic analysis
Whole-cell lysate of strain KCTC 29142 was determined to contain meso-diaminopimelic acid, arabinose, and galactose.
The predominant menaquinone was determined to be MK9(H4).
Phosphatidylethanolamine, phosphatidylglycerol, and phosphatidylinositol were the predominant phospholipids. The cellular fatty acid compositions of strain KCTC 29142 and the three reference strains are listed in Supplementary data Table S2 . The major cellular fatty acids of strain KCTC29142 were found to be iso-C16:0 (19.5%), iso-C16:0 (16.4%), iso-C15:0 (8.5%), and C18:0 (7.8%). These results also suggested that the strain KCTC 29142 belong to the genus Amycolatopsis but have difference with closely related strains.
Isolation and structure elucidation of anti-MRSA compound produced by strain KCTC 29142
The supernatant from flask fermentation was extracted with EtOAc and purified by several chromatographic purification 332 • Lee et al. Fig. S1 , Table 2 ). The coincidence of 1 H-and 13 C-NMR spectroscopic properties of the anti-MRSA compound with the data from previous reports confirmed the compound as siderochelin A (Fig. 3) . The structure was verified by HMBC spectral data (Table 2) .
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Recently, 3 new siderochelins, siderochelin D, E, F were isolated from Amycolatopsis sp. LZ149 (Lu et al., 2015) . These compounds, along with siderochelin A were reported to have anti-mycobacterial activity. In our study, siderochelin A was dominantly isolated from the culture broth.
Anti-MDRP activities of siderochelin A
Siderochelins, which chelate ferrous-ion, are produced from Nocardia sp., Streptoalloteichus sp., and Amycolatopsis sp. (Liu et al., 1981; Okuyama et al., 1982; Mitscher et al., 1984; Lu et al., 2015) . These reports also proposed that siderochelin A has good antibacterial activity. However, the antibacterial activity of siderochelin A on MDRPs had not been investigated until the present study.
The MICs of siderochelin A on clinical isolates of MRSA are summarized in Table 3 . The clinical isolates were susceptible only to vancomycin, and were resistant to either norfloxacin, cephalothin, erythromycin, or oxacillin. However, siderochelin A showed moderate inhibitory activity against all the clinical isolates which is similar with previous reports (Liu et al., 1981; Mitscher et al., 1984) . The MIC for all these isolates was 64 μg/ml. This result implied that the inhibitory activity of siderochelin A is not due to antibiotic mechanism, but may be related with the high iron chelating activity which can limit the growth of pathogens.
Inhibitory effects of siderochelin A on various human infected MDRPs including Gram-positive and Gram-negative bacteria were also investigated (Table 4) . Siderochelin A showed inhibitory activities against MDRPs, but differed in the strains. Siderochelin A showed good activity to E. coli and Acinetobacter baumannii. The MIC of siderochelin A to a susceptible E. coli CCARM 230 and multi-drug resistant E. coli CCARM 1257 are 16 and 32 μg/ml respectively. Siderochelin
A also showed good inhibitory activity against clinical isolates of A. baumannii, which is an increasingly serious threat as a nosocomial pathogen, and displays multi-drug resistance (Kempf and Rolain, 2012) . Even though the A. baumannii isolates used in this study were resistant to cephalothin (MIC 128 to ≥256 μg/ml), they were susceptible to siderochelin A (MIC 32 μg/ml). Siderochelin A showed moderate inhibitory activity against Klebsiella pneumonia and Salmonella enterica strains, the causative pathogen of pneumonia and salmonellosis respectively. Klebsiella pneumoniae CCARM 10074 has extended- spectrum beta-lactamase (ESBL) activity, and K. pneumoniae CCARM 10010 is resistance to ciprofloxacin (MIC ≥128 μg/ml).
All of these strains were inhibited by the siderochelin A with the MIC of 64 μg/ml. However, siderochelin A showed no inhibitory activity against Enterococcus faecium and Pseudomonas aeruginosa (MIC ≥128 μg/ml), which were also major nosocomial infectious pathogens with multi-drug resistance. Different activity may due to the different requirement for iron between pathogens.
Accurate mechanism should be investigated in the future study.
In conclusion, strain KCTC 29142 produces siderochelin A, 
